Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Summary

Cybin Inc. announces CEO Doug Drysdale's presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto, Ontario. The webcast will be live on April 16, 2024, at 1:30 p.m. ET.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, taking place April 16-17, 2024 in Toronto, Ontario.

Mr. Drysdale’s presentation will be webcast live on Tuesday, April 16, 2024, at 1:30 p.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410568951/en/

Investors & Media:

Gabriel Fahel

Chief Legal Officer

Cybin Inc.

1-866-292-4601

irteam@cybin.com – or – media@cybin.com

Source: Cybin Inc.

FAQ

When is Doug Drysdale presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference?

Doug Drysdale will present on April 16, 2024, at 1:30 p.m. ET.

Where will the conference take place?

The conference will be held in Toronto, Ontario.

How can one access the live webcast of the presentation?

To access the live webcast, click on the provided link.

Will the archived webcast be available after the event?

Yes, the archived webcast will be available on the Company's investor relations website.